ScholarGate
Assistente

Comparar métodos

Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.

Inventário Rápido de Sintomatologia Depressiva (QIDS)×Escala de Avaliação de Depressão de Montgomery-Åsberg (MADRS)×
ÁreaPsicologia clínicaPsicologia clínica
FamíliaProcess / pipelineProcess / pipeline
Ano de origem20031979
Autor originalA. John RushStuart Montgomery & Marie Åsberg
TipoSelf-report or clinician-administered questionnaireClinician-rated interview scale
Fonte seminalRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI ↗Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389. DOI ↗
Outros nomesQIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SRMADRS, Montgomery-Asberg Depression Rating Scale
Relacionados45
ResumoThe Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials.The Montgomery-Åsberg Depression Rating Scale is a 10-item clinician-rated assessment designed by Stuart Montgomery and Marie Åsberg in 1979 to measure depression severity and track treatment response. Published in the British Journal of Psychiatry, the MADRS was developed as an alternative to longer instruments like the Hamilton Depression Rating Scale, emphasizing items most sensitive to treatment change. It has become a primary outcome measure in antidepressant trials and is widely used in both research and clinical practice across psychiatry, primary care, and medical specialty settings.
ScholarGateConjunto de dados
  1. v1
  2. 3 Fontes
  3. PUBLISHED
  1. v1
  2. 3 Fontes
  3. PUBLISHED

Ir para a pesquisa Baixar slides

ScholarGateComparar métodos: Quick Inventory of Depressive Symptomatology · Montgomery-Åsberg Depression Rating Scale. Recuperado em 2026-06-19 de https://scholargate.app/pt/compare